Product Information

EVEROLIMUS 0.5 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $2.9773 per EA under NDC 70377007011. Its NADAC has been published 62 times since Sep 17, 2025.

FDA first approved this application on Apr 9, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EVEROLIMUS 0.5 MG TABLET

EVEROLIMUS
$2.9773per EA

Strength

.5 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377007011

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

EVEROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216140

FDA Approved

4/9/2025

TE Code

AB

On Market Since

6/2/2025

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for EVEROLIMUS 0.5 MG TABLET has been published 62 times since Sep 17, 2025, and over the history we have for it it has declined 35.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9773 per EA
All-time high$4.6246 (Oct 15, 2025)
All-time low$2.9773 (Nov 18, 2026)
52-week high$4.2997
52-week low$2.9773
Median price$3.8410
Average price$3.8791
Largest weekly change-9.1% (Oct 21, 2026)
Weeks tracked62
Tracking sinceSep 17, 2025

Price History

1W

-7.0%

1M

-15.5%

3M

-20.7%

6M

-17.4%

1Y

-32.3%

3Y

N/A

5Y

N/A

All

-35.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the EVEROLIMUS market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EVEROLIMUS 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.5 MG TABLET, manufactured by Biocon Pharma Inc., is $2.9773 per EA (NDC 70377007011), effective Nov 18, 2026.

How has the price of EVEROLIMUS 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for EVEROLIMUS 0.5 MG TABLET has declined 35.6%. It has been tracked across 62 weekly CMS publications since Sep 17, 2025.

What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.5 MG TABLET?

Since Sep 17, 2025, the NADAC for EVEROLIMUS 0.5 MG TABLET has ranged from a low of $2.9773 (Nov 18, 2026) to a high of $4.6246 (Oct 15, 2025), with a median of $3.8410 per EA.

Are there cheaper alternatives to EVEROLIMUS 0.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of EVEROLIMUS 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures EVEROLIMUS 0.5 MG TABLET?

EVEROLIMUS 0.5 MG TABLET (NDC 70377007011) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.